Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L R Wiseman

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Pharmacoeconomics|May 27, 1999
Docetaxel. A pharmacoeconomic review of its use in the treatment of metastatic breast cancerH M Lamb, L R Wiseman
Drugs & Aging|May 8, 1998
Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancersL R Wiseman, C M Spencer
Drugs|April 1, 1996
Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosisJ C Gillis, L R Wiseman
Drugs & Aging|November 7, 1998
Anastrozole. A review of its use in the management of postmenopausal women with advanced breast cancerL R Wiseman, J C Adkins
Drugs|June 9, 1998
Moexipril. A review of its use in the management of essential hypertensionR N Brogden, L R Wiseman
Drugs|April 8, 1999
MoxifloxacinJ A Balfour, L R Wiseman
Drugs|July 1, 1996
Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain managementR N Brogden, L R Wiseman
Drugs|October 20, 1998
Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapyL R Wiseman, C M Spencer
Drugs|July 1, 1997
Toremifene. A review of its pharmacological properties and clinical efficacy in the management of advanced breast cancerL R Wiseman, K L Goa
Drugs & Aging|June 1, 1997
Mitoxantrone. A review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancerL R Wiseman, C M Spencer
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Pharmacoeconomics|May 27, 1999
Docetaxel. A pharmacoeconomic review of its use in the treatment of metastatic breast cancerH M Lamb, L R Wiseman
Drugs & Aging|May 8, 1998
Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancersL R Wiseman, C M Spencer
Drugs|April 1, 1996
Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosisJ C Gillis, L R Wiseman
Drugs & Aging|November 7, 1998
Anastrozole. A review of its use in the management of postmenopausal women with advanced breast cancerL R Wiseman, J C Adkins
Drugs|June 9, 1998
Moexipril. A review of its use in the management of essential hypertensionR N Brogden, L R Wiseman
Drugs|April 8, 1999
MoxifloxacinJ A Balfour, L R Wiseman
Drugs|July 1, 1996
Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain managementR N Brogden, L R Wiseman
Drugs|October 20, 1998
Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapyL R Wiseman, C M Spencer
Drugs|July 1, 1997
Toremifene. A review of its pharmacological properties and clinical efficacy in the management of advanced breast cancerL R Wiseman, K L Goa
Drugs & Aging|June 1, 1997
Mitoxantrone. A review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancerL R Wiseman, C M Spencer
Pageof 5